These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18571396)

  • 21. Going soft on evidence and due process: Canada adopts US style harm maximization.
    Wodak A
    Int J Drug Policy; 2008 Jun; 19(3):226-8; discussion 233-4. PubMed ID: 18424112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug policing, harm reduction and health: directions for advocacy.
    Burris S; Burrows D
    Int J Drug Policy; 2009 Jul; 20(4):293-5. PubMed ID: 19403297
    [No Abstract]   [Full Text] [Related]  

  • 23. The influence of ''No Child Left Behind'' legislation on drug prevention in US Schools.
    Cho H; Dion Hallfors D; Iritani BJ; Hartman S
    Eval Rev; 2009 Oct; 33(5):446-63. PubMed ID: 19429841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strengthening drug policy and practice through ethics engagement: an old challenge for a new harm reduction.
    Irwin KS; Fry CL
    Int J Drug Policy; 2007 Mar; 18(2):75-83. PubMed ID: 17689348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Political and legal institutions and their influence on drug policy: an Australian perspective.
    Ryder D
    Drug Alcohol Rev; 2008 Jul; 27(4):374-9. PubMed ID: 18584386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Harm reduction drug policies and practice: international developments and domestic initiatives. Overview of a symposium. March 22, 1995.
    Drucker E; Hantman JA
    Bull N Y Acad Med; 1995; 72(2):335-8. PubMed ID: 10101373
    [No Abstract]   [Full Text] [Related]  

  • 27. [The issue of harm reduction in Polish legislation concerning drug addiction. A comparative study].
    Sobeyko J
    Ann Acad Med Stetin; 2008; 54(2):119-31. PubMed ID: 19374242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A critical evaluation of the European Drug Strategy: has it brought added value to drug policy making at the national level?
    Chatwin C
    Int J Drug Policy; 2013 May; 24(3):251-6. PubMed ID: 23238457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ethical, legal and social context of harm reduction.
    Pauly B; Goldstone I; McCall J; Gold F; Payne S
    Can Nurse; 2007 Oct; 103(8):19-23. PubMed ID: 17990401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A safe, sensible and social AHRSE: New Labour and alcohol policy.
    Anderson P
    Addiction; 2007 Oct; 102(10):1515-21. PubMed ID: 17854326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current drug policies: the Geneva example].
    Mino A
    Schweiz Rundsch Med Prax; 1994 Aug; 83(34):950-6. PubMed ID: 7939047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effective drug policy: a new approach demonstrated in the Drug Policy Modelling Program.
    Ritter A; Bammer G; Hamilton M; Mazerolle L;
    Drug Alcohol Rev; 2007 May; 26(3):265-71. PubMed ID: 17454015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Canadian perspective on addiction treatment.
    El-Guebaly N
    Subst Abus; 2014; 35(3):298-303. PubMed ID: 24857633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Policy in matters of drug abuse. Analysis of the report of the expert commission for the revision of the federal law on narcotics (February 1996)].
    Martin J
    Rev Med Suisse Romande; 1996 Aug; 116(8):651-3. PubMed ID: 8848690
    [No Abstract]   [Full Text] [Related]  

  • 35. When is alcohol just another drug? Some thoughts on research and policy.
    Cook PJ; Reuter P
    Addiction; 2007 Aug; 102(8):1183-8. PubMed ID: 17624970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Capitalising upon political opportunities to reform drug policy: a case study into the development of the Australian "Tough on Drugs-Illicit Drug Diversion Initiative".
    Hughes CE
    Int J Drug Policy; 2009 Sep; 20(5):431-7. PubMed ID: 19162458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ten years after the United Nations General Assembly Special Session (UNGASS): assessing drug problems, policies and reform proposals.
    Reuter P
    Addiction; 2009 Apr; 104(4):510-7. PubMed ID: 19335650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defining harm reduction.
    Single E
    Drug Alcohol Rev; 1995; 14(3):287-90. PubMed ID: 16203323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A question of balance: prioritizing public health responses to harm from gambling.
    Adams PJ; Raeburn J; de Silva K
    Addiction; 2009 May; 104(5):688-91. PubMed ID: 19215607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Harm reduction headway and continuing resistance: insights from safe injection in the city of Vancouver.
    Hathaway AD; Tousaw KI
    Int J Drug Policy; 2008 Feb; 19(1):11-6. PubMed ID: 18164610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.